GlassScriptPhysician profile
Michael R Hausman
NPI 1063475069
$128,244.55
in general payments reported to CMS, 2019-2025
12 companies · $31K in 2025
The $31K reported for 2025 was more than what 97% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54K · 2020: $5,357 · 2021: $71.12 · 2022: $19K · 2023: $7,284 · 2024: $12K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $19K · Consulting Fee: $16K · Royalty Or License: $7,364 · Food and Beverage: $4,324 · Honoraria: $3,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $19,248.63 |
| Consulting Fee | $15,778.48 |
| Royalty Or License | $7,364.33 |
| Food and Beverage | $4,323.61 |
| Honoraria | $3,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $111,220.90 | 2019-2025 | |
| Skeletal Dynamics INC | $8,659.81 | 2019-2025 | Geminus, Ijs, Align |
| Checkpoint Surgical, INC | $5,965.63 | 2019-2025 | Checkpoint Stimulators |
| Gotham Surgical Solutions & Devices, INC. | $1,200.00 | 2022 | |
| Depuy Synthes Sales INC. | $357.06 | 2023-2025 | Dynacord, Quickanchor Ethibond, Quickanchor Orthocord |
| Integra Lifesciences Corporation | $243.70 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Djo, LLC | $242.84 | 2023-2024 | Cmf |
| Axogen | $200.49 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Stryker Corporation | $103.28 | 2022 | |
| Suvon Surgical LLC | $26.70 | 2025 | |
| Smith+Nephew, INC. | $24.14 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,946,587.45 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hausman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.